Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ELAN

Elanco

$0.00

(0.00%)

, LLY

Eli Lilly

$105.83

-1.06 (-0.99%)

13:51
09/19/18
09/19
13:51
09/19/18
13:51
Initiation
Elanco, Eli Lilly initiated at Gabelli »

Elanco initiated with a…

ELAN

Elanco

$0.00

(0.00%)

LLY

Eli Lilly

$105.83

-1.06 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 01

    Oct

  • 04

    Oct

  • 20

    Sep

NVS

Novartis

$84.55

-0.48 (-0.56%)

, TCEHY

Tencent

$0.00

(0.00%)

10:59
09/19/18
09/19
10:59
09/19/18
10:59
Periodicals
Novartis, Tencent to partner, focus on cardiovascular disease, Bloomberg says »

Bloomberg cites an email…

NVS

Novartis

$84.55

-0.48 (-0.56%)

TCEHY

Tencent

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

NVS

Novartis

$84.18

-0.85 (-1.00%)

09:45
09/19/18
09/19
09:45
09/19/18
09:45
Conference/Events
Novartis has a conference call hosted by JPMorgan »

JPMorgan Analyst Vosser …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

ABBV

AbbVie

$92.60

-2.77 (-2.90%)

, GSK

GlaxoSmithKline

$39.62

0.415 (1.06%)

09:37
09/19/18
09/19
09:37
09/19/18
09:37
Recommendations
AbbVie, GlaxoSmithKline analyst commentary at Morgan Stanley »

Morgan Stanley says…

ABBV

AbbVie

$92.60

-2.77 (-2.90%)

GSK

GlaxoSmithKline

$39.62

0.415 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$92.60

-2.77 (-2.90%)

09:05
09/19/18
09/19
09:05
09/19/18
09:05
Recommendations
AbbVie analyst commentary at Credit Suisse »

AbbVie's California…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$85.03

-0.1 (-0.12%)

08:46
09/19/18
09/19
08:46
09/19/18
08:46
Conference/Events
Novartis has a conference call hosted by JPMorgan »

JPMorgan Analyst Vosser …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

AMRX

Amneal Pharmaceuticals

$23.46

0.62 (2.71%)

, JAZZ

Jazz Pharmaceuticals

$161.89

0.92 (0.57%)

08:38
09/19/18
09/19
08:38
09/19/18
08:38
Recommendations
Amneal Pharmaceuticals, Jazz Pharmaceuticals, Mylan, Amgen, Teva analyst commentary at Leerink »

Leerink…

AMRX

Amneal Pharmaceuticals

$23.46

0.62 (2.71%)

JAZZ

Jazz Pharmaceuticals

$161.89

0.92 (0.57%)

MYL

Mylan

$37.80

0.59 (1.59%)

AMGN

Amgen

$202.32

1.5 (0.75%)

TEVA

Teva

$24.50

1.06 (4.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 01

    Oct

  • 17

    Oct

  • 22

    Oct

  • 27

    Oct

  • 09

    Nov

  • 13

    Nov

  • 27

    Nov

  • 20

    Dec

NVS

Novartis

$85.03

-0.1 (-0.12%)

06:18
09/19/18
09/19
06:18
09/19/18
06:18
Hot Stocks
Novartis' Kymriah for adult lymphoma 'to expensive to recommend,' says NICE »

The U.K.'s National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

DCPH

Deciphera

$36.16

1.48 (4.27%)

, NVS

Novartis

$85.03

-0.1 (-0.12%)

05:21
09/19/18
09/19
05:21
09/19/18
05:21
Recommendations
Deciphera, Novartis, Blueprint Medicines analyst commentary at Piper Jaffray »

Piper recommends…

DCPH

Deciphera

$36.16

1.48 (4.27%)

NVS

Novartis

$85.03

-0.1 (-0.12%)

BPMC

Blueprint Medicines

$70.95

2.33 (3.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 01

    Oct

  • 27

    Nov

ABBV

AbbVie

$92.60

-2.77 (-2.90%)

05:07
09/19/18
09/19
05:07
09/19/18
05:07
Recommendations
AbbVie analyst commentary at Piper Jaffray »

Piper more worried about…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.